CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. is a joint venture company headquartered in Gurgaon, India. The firm develops and researches vaccines. It was founded in 2009. Raman Rao has been the CEO since 2020.\nThe company says this about itself: Hilleman Laboratories was established as an equal joint venture by MSD and Wellcome Trust in 2009, headquartered in New Delhi, India. Hilleman Laboratories is a global vaccine R&D organization committed to developing high impact, affordable vaccines for low- and middle- income countries. Our translational research focuses on creating safe, low-cost vaccines and innovative delivery technologies that are highly effective and can be easily incorporated into immunization programs. Hilleman Lab��s focus is on transforming ideas into products and technologies through translational R&D and by building partnerships with global stakeholders and vaccine manufacturers.

Wuhu Kangwei Biotechnology Co. Ltd. is a Chinese private company located in Wuhu specializing in biological products, except diagnostic substances.

Crucell Sweden AB is a Swedish registered company with in-house development and manufacturing capabilities, marketing their specialist vaccines internationally. A complete vaccine portfolio sourced from global vaccine companies is marketed in the Nordic region by their distribution division based in Stockholm.\nCrucell is a global biopharmaceutical company dedicated to bringing meaningful innovation to global health. Crucell focuses on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide. Currently they are combating twelve major infectious diseases with their range of marketed vaccines in the pediatric, travel and endemic and respiratory fields.

USAMRMC

Gotovax AB is a private company headquartered in Sweden that engages in research and development on natural sciences and engineering.

Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the sale of gastrointestinal drugs such as Seirogan, Seirogan Toui A, and Seirogan Quick C. The Infection Control segment offers hygiene products such as Cleverin and clev&and. The Others segment provides vinegar-related products. The company was founded by Otojiro Shibata in July 1940 and is headquartered in Osaka, Japan.

Hawker is a exploration and production company, cast aside its drug candidates to explore the Western Canada Sedimentary Basin for natural gas and oil. Hawker Resources acquired fellow explorers Southward Energy and ZORIN Exploration in 2003 and 2004, respectively. In 2005 it also acquired Iteration Energy, an oil and gas company, and is divesting its Lavoy area assets. After the divestiture, the company will have proved reserves of about 3.8 million barrels of oil equivalent and proved plus probable reserves of 5.7 million barrels of oil equivalent.

SBL Vaccin AB manufactures and distributes vaccines. Its products are used for the treatment of polio, diarrhoea, and cholera diseases. The company distributes products to the healthcare centers, hospitals, schools, and industrial healthcare units. SBL Vaccin was founded in 1957 and is located in Solna, Sweden.

Distributor of pharmaceutical goods

Acambis Research Ltd. is a British joint venture company located in Reading that engages in research and experimental development on natural sciences and engineering. It was founded in 1992.

Sinopharm Yangzhou Weike Bioengineering Co., Ltd., established on 2004-04-23, Business scope includes research and development,Production,Sales of veterinary biological products,veterinary medicine,additive.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Import and export;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Develops and manufactures natural food additives, veterinary vaccines and pharmaceuticals

Ningbo Health Gene Technologies Co. Ltd. is a Chinese company that develops and researches nucleic acid testing solutions for molecular diagnostics, clinical research and forensic analysis.

Nanjing Tianbang Bio Technology Co., Ltd., part of Beijing Dabeinong Technology Group Co., Ltd., is a Chinese company located in Nanjing. The firm engages in researching and developing animal bio products. On March 12, 2014 Beijing Dabeinong Technology Group Co., Ltd. acquired Nanjing Tianbang Bio Technology Co., Ltd. for $1.94 million.

Hubei Shendi Biotechnology Co., Ltd., established on 2008-03-11, Business scope includes biotechnology development,Acquisition of agricultural products(Does not contain grain),Deep Processing;Production of agricultural by-products,processing,Sales;cosmetic,daily necessities,Pre-packaged food,dairy products(Does not contain infant formula),food grade ingredients,Pharmaceutical Grade Ingredients,Research and development of powdered egg feed,Production,Sales;Cold storage rental,Cargo storage leasing and cargo transportation;"Import and export","Technology Import and Export"and"Agent import and export"(Excludes businesses that are prohibited or restricted from import and export by the state).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Meikang Gene Science Co., Ltd., established on 2005-08-30, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Experimental analysis instrument sales;Chemical product sales(No licensed chemical products);Electronic Components Retail;Retailing of computer software, hardware and auxiliary equipment;Animal Husbandry and Fishery Feed Sales;Import and export;Class I Medical Device Leasing;Biochemical product technology research and development;General merchandise sales;Domestic trade agent;food sales(Only sell prepackaged food);Sales of plastic products;Household Appliances Retail;software development;rental service(Licensed rental services not included);Socioeconomic Advisory Services;internet sales(Except for products that require a license for sale);Health Consulting Services(Does not include medical services).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)